Stephen B. Shrewsbury - 29 Mar 2022 Form 4 Insider Report for IMPEL NEUROPHARMA INC

Role
Chief Medical Officer
Signature
/s/ John Leaman, M.D. as attorney-in-fact
Issuer symbol
N/A
Transactions as of
29 Mar 2022
Net transactions value
+$48,474
Form type
4
Filing time
30 Mar 2022, 21:54:03 UTC
Previous filing
28 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMPL Common Stock Options Exercise $48,474 +24,606 +34% $1.97 97,990 29 Mar 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMPL Stock Option (right to buy) Options Exercise $0 -24,606 -100% $0.000000* 0 29 Mar 2022 Common Stock 24,606 $1.97 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is 100% vested and exercisable.